RU92004423A - CURCUMA PLANT PRODUCT - Google Patents

CURCUMA PLANT PRODUCT

Info

Publication number
RU92004423A
RU92004423A RU92004423/14A RU92004423A RU92004423A RU 92004423 A RU92004423 A RU 92004423A RU 92004423/14 A RU92004423/14 A RU 92004423/14A RU 92004423 A RU92004423 A RU 92004423A RU 92004423 A RU92004423 A RU 92004423A
Authority
RU
Russia
Prior art keywords
curcumin
plant product
curcuma plant
curcuma
leukotrienes
Prior art date
Application number
RU92004423/14A
Other languages
Russian (ru)
Other versions
RU2121832C1 (en
Inventor
Г.П.Т. Аммон
Хасан Сафайхи
Самюэль Хвахикву Окпании
Original Assignee
Штайгервальд Арцнаймиттельверк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4137540A external-priority patent/DE4137540A1/en
Application filed by Штайгервальд Арцнаймиттельверк filed Critical Штайгервальд Арцнаймиттельверк
Publication of RU92004423A publication Critical patent/RU92004423A/en
Application granted granted Critical
Publication of RU2121832C1 publication Critical patent/RU2121832C1/en

Links

Claims (1)

Изобретение относится к применению препаратов растения Curcuma longa или других растений, содержащих куркумин, куркумина или производных куркумина для профилактики и/или лечения заболеваний, сопровождающихся чрезмерным образованием лейкотриенов и/или простагландинов, а также к применению препаратов растения Curcuma longa или других растений, содержащих куркумин или производные куркумина, для приготовления лекарственных средств для профилактики и/или лечения заболеваний, сопровождающихся чрезмерным образованием лейкотриенов и/или простагландинов.The invention relates to the use of preparations of the Curcuma longa plant or other plants containing curcumin, curcumin or curcumin derivatives for the prevention and / or treatment of diseases accompanied by excessive formation of leukotrienes and / or prostaglandins, as well as the use of preparations of the Curcuma longa plant or other plants containing curcumin or curcumin derivatives, for the preparation of drugs for the prevention and / or treatment of diseases accompanied by excessive formation of leukotrienes and / or prostagland new.
RU92004423A 1991-11-14 1992-11-12 Agent for prophylaxis and/or treatment of patients with diseases accompanying the excessive synthesis of leukotrienes and/or prostaglandins RU2121832C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEP4137540.8 1991-11-14
DE4137540A DE4137540A1 (en) 1991-11-14 1991-11-14 USE OF PREPARATIONS OF CURCUMA PLANTS
US07/974,056 US5401777A (en) 1991-11-14 1992-11-10 Use of preparations of curcuma plants

Publications (2)

Publication Number Publication Date
RU92004423A true RU92004423A (en) 1997-01-27
RU2121832C1 RU2121832C1 (en) 1998-11-20

Family

ID=25909167

Family Applications (1)

Application Number Title Priority Date Filing Date
RU92004423A RU2121832C1 (en) 1991-11-14 1992-11-12 Agent for prophylaxis and/or treatment of patients with diseases accompanying the excessive synthesis of leukotrienes and/or prostaglandins

Country Status (12)

Country Link
US (1) US5401777A (en)
EP (2) EP0550807A3 (en)
JP (1) JPH05262659A (en)
CA (1) CA2082562A1 (en)
CZ (1) CZ288163B6 (en)
DE (1) DE4137540A1 (en)
EG (1) EG20056A (en)
HU (1) HUT62801A (en)
PL (1) PL296570A1 (en)
RU (1) RU2121832C1 (en)
SK (1) SK281947B6 (en)
ZA (1) ZA928554B (en)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925376C1 (en) * 1994-01-10 2001-03-20 Madalene C Y Heng Method for treating psoriasis using selected phosphorylase kinase inhibitor and additional compounds
ES2081264B1 (en) * 1994-08-03 1996-08-16 A C Pharmaceutical Internation PROCEDURE FOR OBTAINING APCOLAR AND POLAR EXTRACTS FROM CURCUMA AND APPLICATIONS THEREOF.
ES2197203T3 (en) * 1994-08-03 2004-01-01 A.S.A.C. Pharmaceutical International, A.I.E. METHOD OF OBTAINING APOLAR AND POLAR EXTRACTS FROM CURCUMA AND APPLICATIONS OF THE SAME.
EP0839037B1 (en) * 1995-07-14 2002-11-13 Sabinsa Corporation Bioprotectant composition, method of use and extraction process of curcuminoids
AU6977396A (en) * 1995-09-14 1997-04-01 Research Development Foundation Curcumin (diferuloylmethane) inhibition of nf$g(k)b activation
US5861415A (en) * 1996-07-12 1999-01-19 Sami Chemicals & Extracts, Ltd. Bioprotectant composition, method of use and extraction process of curcuminoids
GB9711962D0 (en) * 1997-06-10 1997-08-06 Reckitt & Colmann Prod Ltd Therapeutically active compositions
EP1045822B1 (en) 1998-01-09 2003-05-07 Eurovita A/S Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments
US6210701B1 (en) 1999-04-30 2001-04-03 Healthcomm International, Inc. Medical food for treating inflammation-related diseases
US20010051184A1 (en) * 1999-05-20 2001-12-13 Madalene C.Y. Heng Method for using soluble curcumin to inhibit phosphorylase kinase in inflammatory diseases
US6673843B2 (en) * 1999-06-30 2004-01-06 Emory University Curcumin and curcuminoid inhibition of angiogenesis
ES2154610B1 (en) * 1999-09-23 2001-11-16 Asac Compania De Biotecnologia NEW PHARMACOLOGICAL ACTIVITIES OF CURCUMA LONGA EXTRACTS.
US20030149113A1 (en) * 2001-10-12 2003-08-07 Caplan Michael J. Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
US20040266883A1 (en) * 1999-10-27 2004-12-30 Yale University Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
US20030236300A1 (en) * 1999-10-27 2003-12-25 Yale University Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
US7893226B2 (en) 2004-09-29 2011-02-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Use of lipid conjugates in the treatment of diseases
US8501701B2 (en) * 2000-01-10 2013-08-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Use of lipid conjugates in the treatment of disease
US8916539B2 (en) * 2000-01-10 2014-12-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of disease
US8304395B2 (en) * 2000-01-10 2012-11-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Lipid conjugates in the treatment of disease
US7608598B2 (en) 2000-01-10 2009-10-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of conjunctivitis
US7772196B2 (en) * 2000-01-10 2010-08-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases
US7811999B2 (en) * 2000-01-10 2010-10-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Use of lipid conjugates in the treatment of diseases
US20090325876A1 (en) * 2004-09-29 2009-12-31 Saul Yedgar Use of lipid conjugates in the treatment of diseases associated with vasculature
US8076312B2 (en) * 2000-01-10 2011-12-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Use of lipid conjugates in the treatment of disease
US9040078B2 (en) * 2000-01-10 2015-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases of the nervous system
AU2001266895A1 (en) * 2000-06-13 2001-12-24 Wyeth Phytonutrient formula for the relief of chronic pain resulting from inflammation
US6492429B1 (en) 2000-07-10 2002-12-10 N.V. Nutricia Composition for the treatment of osteoarthritis
US8883761B2 (en) * 2001-01-10 2014-11-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases associated with vasculature
KR20020073847A (en) * 2001-03-16 2002-09-28 주식회사 바이오시너젠 Composition for preventing or treating dementia comprising curcumin or extract of curcuma aromatica
US6387416B1 (en) * 2001-04-05 2002-05-14 Thomas Newmark Anti-Inflammatory herbal composition and method of use
US20040037903A1 (en) * 2001-06-13 2004-02-26 Lemmo Edward A. Phytonutrient formula for the relief of chronic pain resulting from inflammation
US6596313B2 (en) * 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it
JP5384777B2 (en) * 2001-12-18 2014-01-08 有限会社大長企画 Strong muscle agent, anti-inflammatory agent
JP2012149096A (en) * 2001-12-18 2012-08-09 Daicho Kikaku:Kk Anti-inflammatory preparation
US20090011991A1 (en) * 2002-03-08 2009-01-08 Emory University Novel Curcuminoid-Factor VIIA Constructs as Suppressors of Tumor Growth and Angiogenesis
CA2478522A1 (en) * 2002-03-08 2003-09-18 Emory University Novel curcuminoid-factor viia constructs as suppressors of tumor growth and angiogenesis
KR20030074017A (en) * 2002-03-15 2003-09-19 한국생명공학연구원 Method of preparing curcumin and its derivatives and pharmaceutical compositions for the prevention and treatment of cancers comprising the same
US6811796B2 (en) 2002-04-22 2004-11-02 Matsuura Yakugyo Co., Ltd. Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof
EP1496880A4 (en) * 2002-04-24 2007-12-12 Res Dev Foundation SYNERGISTIC EFFECTS OF NUCLEAR TRANSCRIPTION FACTOR NF-kB INHIBITORS AND ANTI-NEOPLASTIC AGENTS
WO2004000229A2 (en) * 2002-06-24 2003-12-31 Research Development Foundation Treatment of human multiple myeloma by curcumin
US7060733B2 (en) * 2002-08-15 2006-06-13 The Regents Of The University Of California Methods for treating pancreatitis with curcumin compounds and inhibitors of reactive oxygen species
US20040259816A1 (en) * 2002-10-01 2004-12-23 Pandol Stephen J. Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof
PT2238982E (en) * 2003-06-27 2013-01-22 Astellas Pharma Inc Therapeutic agent for soft tissue sarcoma
EP1658061A2 (en) * 2003-08-26 2006-05-24 Research Development Foundation Aerosol delivery of curcumin
CA2536380A1 (en) 2003-08-26 2005-02-26 Research Development Foundation Osteoclastogenesis inhibitors and uses thereof
US20050244522A1 (en) * 2004-04-30 2005-11-03 Carrara Dario Norberto R Permeation enhancer comprising genus Curcuma or germacrone for transdermal and topical administration of active agents
US20050267221A1 (en) * 2004-05-14 2005-12-01 Research Development Foundation Use of curcumin and analogues thereof as inhibitors of ACC2
AU2005274765B2 (en) * 2004-07-23 2012-08-30 Arjil Pharmaceuticals Llc Anti-hypersensitive inflammation and anti-allergy activities of Zingiber zerumbet (L.) Smith
US7514092B2 (en) * 2004-12-22 2009-04-07 Avon Products, Inc. Compositions and methods of their use for improving the condition and appearance of skin
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis
JP5032003B2 (en) * 2005-06-15 2012-09-26 株式会社琉球バイオリソース開発 Analgesic and anti-inflammatory lozenges for oral mucosa
CA2611489A1 (en) * 2005-06-15 2006-12-28 Darrick S.H.L. Kim Synergistic pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease including sage and rosemary derived compounds
CN104546891A (en) * 2005-08-03 2015-04-29 塞尔索斯治疗公司 Use of lipid conjugates in cystic fibrosis and applications thereof
WO2007046113A2 (en) * 2005-10-18 2007-04-26 Panacea Biotec Ltd. Novel pharmaceutical composition comprising alkaloid and process thereof
US20110130555A1 (en) 2009-05-11 2011-06-02 Saul Yedgar Lipid-polymer conjugates, their preparation and uses thereof
US8906882B2 (en) 2005-11-17 2014-12-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Lipid conjugates in the treatment of allergic rhinitis
US8859524B2 (en) 2005-11-17 2014-10-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Lipid conjugates in the treatment of chronic rhinosinusitis
US20070160696A1 (en) * 2006-01-11 2007-07-12 The Procter & Gamble Company Compositions and methods useful for prevention or treatment of respiratory illness
US20080075671A1 (en) * 2006-09-22 2008-03-27 Di Mauro Thomas M Intranasally administering curcumin to the brain to treat alzheimer's disease
US20090087385A1 (en) * 2006-09-22 2009-04-02 Di Mauro Thomas M Intranasally administering curcumin in a bolus of helium gas to treat alzheimers disease
CA2705785A1 (en) * 2006-11-14 2008-05-22 Saul Yedgar Use of lipid conjugates in the treatment of diseases or disorders of the eye
US8383865B2 (en) * 2007-04-17 2013-02-26 Codman & Shurtleff, Inc. Curcumin derivatives
ES2562205T3 (en) * 2007-04-17 2016-03-03 Codman & Shurtleff, Inc. Resveratrol curcumin hybrids
DE102007047237B4 (en) * 2007-10-02 2011-07-14 Busch, Klaus-Uwe, Dr. Composition of substances and their use as oral hygiene products and dietary supplements
WO2009043176A1 (en) * 2007-10-03 2009-04-09 Sabell Corporation Herbal compositions and methods for treating hepatic disorders
ITMI20072315A1 (en) * 2007-12-11 2009-06-12 Bios Line Spa ORAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF COLON DISORDERS ON AN INFLAMMATORY BASIS
CN101903034B (en) 2007-12-21 2013-07-31 Asac生物技术研究股份公司 Method for increasing the therapeutic efficacy of curcuminoids and analogues
US7745670B2 (en) * 2008-06-27 2010-06-29 Codman & Shurtleff, Inc. Curcumin-Resveratrol hybrid molecule
JP5758563B2 (en) * 2008-03-28 2015-08-05 丸善製薬株式会社 Hyaluronidase activity inhibitor and tumor necrosis factor production inhibitor
US7985776B2 (en) 2008-06-27 2011-07-26 Codman & Shurtleff, Inc. Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease
JP2012510466A (en) * 2008-12-01 2012-05-10 ライラ ファーマシューティカルズ ピーブイティ．エルティディ． Topical formulations for the treatment of inflammation, skin and mucosal abnormalities and other skin and mucosal diseases
US20100150865A1 (en) * 2008-12-11 2010-06-17 Deepa Chitre Novel formulations to inhibit cyclooxygenase and pro-inflammatory cytokine mediated diseases
US20100286585A1 (en) * 2009-01-26 2010-11-11 Codman & Shurtleff, Inc. Shunt Delivery of Curcumin
US7723515B1 (en) 2009-01-26 2010-05-25 Codman & Shurtleff, Inc. Methylene blue—curcumin analog for the treatment of alzheimer's disease
JP2012521412A (en) * 2009-03-23 2012-09-13 ライラ ファーマシューティカルズ ピーブイティ．エルティディ． Curcuminoids and their metabolites for application in nasal allergic diseases
BR112013018933A2 (en) * 2011-02-10 2016-09-13 Unilever Nv antiviral, liquid antiseptic, and personal cleansing compositions for solid and liquid hard surface cleaning, antimicrobial, hand sanitizer, surface disinfection method and use of a composition
KR101416149B1 (en) * 2011-04-20 2014-07-09 한국생명공학연구원 Composition comprising an extract of Curcuma longa L. or Curcuma aromatica L. isolated therefrom having IL-6 induced STAT3 inhibitory activity
ITMI20111259A1 (en) * 2011-07-06 2013-01-07 Eye Tech Srl QUICK-RELEASE ORO-SOLUBLE COMPOSITION CONTAINING CURCUMINE DERIVATIVES
RU2508118C1 (en) * 2012-06-27 2014-02-27 Федеральное государственное казенное военное образовательное учреждение высшего профессионального образования "Военная академия радиационной, химической и биологической защиты имени Маршала Советского Союза С.К. Тимошенко (г. Кострома)" Министерства обороны Российской Федерации Method for increasing radioresistance in mice
DK3102185T3 (en) 2014-02-03 2021-10-04 Apurano Pharmaceuticals Gmbh NANOSUS SUSPENSION OF NATURAL MATERIALS AND PROCEDURE
EP3131636A4 (en) * 2014-04-18 2018-01-10 OmniActive Health Technologies Limited Curcumin compositions and uses thereof
CN104189725A (en) * 2014-07-24 2014-12-10 汪升静 Traditional Chinese medicine composition for treating infantile asthma
JP2015006444A (en) * 2014-09-19 2015-01-15 スミス・アンド・ネフュー・オルソペディクス・アーゲー Medical implant with abrasion particles excellent in response of body
US20200360300A1 (en) * 2014-12-31 2020-11-19 Signpath Pharma, Inc. Suppression of Cytokine Release and Cytokine Storm
DE102015008823A1 (en) * 2015-07-15 2017-01-19 Hans Muerth Use of the method and apparatus for vaporizing curcumin powder with a high performance evaporator to produce an inhalable curcumin aerosol
RU2743427C1 (en) * 2020-02-26 2021-02-18 Федеральное государственное бюджетное образовательное учреждение высшего образования "Южно-Уральский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО ЮУГМУ Минздрава России) Rectal suppositories, having anti-inflammatory, antioxidant, immunostimulating action, containing rhizomes with common turmeric roots

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07110828B2 (en) * 1987-07-30 1995-11-29 株式会社ヤクルト本社 Diphenylheptenone derivative and hepatic disorder therapeutic agent containing the same
US5120538A (en) * 1990-02-05 1992-06-09 Pt Darya-Varia Laboratoria Combinations of compounds isolated from curcuma spp as anti-inflammatory agents

Similar Documents

Publication Publication Date Title
RU92004423A (en) CURCUMA PLANT PRODUCT
BR8602864A (en) COMPOUNDS, PROCESS FOR THEIR PREPARATION, MICROBICIDE COMPOSITION, PROCESSES FOR THE PREPARATION OF A COMPOSITION AND FOR COMBATING OR PREVENTING A PLANT INFESTATION, PROCESS FOR DISINFECTING SEEDS AND EMPLOYMENT
FR2416012A1 (en) DERIVATIVES OF IMIDAZOLE AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
IT8024745A0 (en) PHENOXES PHENYLYSOTHIOUREE, PROCEDURE FOR THEIR PREPARATION AND THEIR USE TO FIGHT HARMFUL ORGANISMS AND ALSO PHENOXY PHENYLTHIOUREE AS INTERMEDIATE PRODUCTS FOR THE PREPARATION OF PHENOXY PHENYLYSOTHIOUREE AND ALSO THEIR USE TO FIGHT HARMFUL ORGANISMS.
PT74586B (en) Process for the preparation emulsions of the tyre oil-in-water specially appropriate for being used as formulations of agro- chemical compositions for combating pests in the domestic field and hygiene field and/or of pharmaceutical compositions
DE59208062D1 (en) Pesticide formulations in the form of microcapsules
RU92016463A (en) APPLICATION OF DERIVATIVES OF TISSTINES FOR THE MANUFACTURE OF MEDICINES WITH IMMUNOMODING EFFECT, PHARMACEUTICAL COMPOSITIONS ON THEIR BASIS
MA19882A1 (en) Derivatives of w-amino acids, their preparation and use as well as the compositions containing these acids.
EP0308044A3 (en) Azadirachtin derivative insecticides
BG101709A (en) New applications of lysozyme dimer
IT7826042A0 (en) 6,7-DI-HYDRO-5H,13H-QUINAZOLINE OPEN SQUARE BRACKET 3,2-A CLOSE SQUARE BRACKET OPEN SQUARE BRACKET 1,4 CLOSE SQUARE BRACKET BENZODIAZEPIN-5,13-DIONS, PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS.
IT7825386A0 (en) N-ARIL-N'-ALKYL-S-ALKYL-ISOTHIOURE AND, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS PRODUCTS TO FIGHT ANIMAL AND PLANT HARMFUL ORGANISMS.
OA07540A (en) New derivatives of cyclopropane carboxylic acid, their preparation, their application to the fight against parasites and the compositions containing them.
IT8026233A0 (en) DERIVATIVE OF N-ACETYL-CYSTEINE WITH THERAPEUTIC ACTIVITY, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
IT8222840A0 (en) DERIVATIVES OF AMINO AND DIAMINO-ACIDS, THEIR PRODUCTION PROCEDURE AND THEIR USE AS PLANT GROWTH STIMULANTS AND AS PHARMACEUTICAL PRODUCTS.
BE877658A (en) NOVEL ACETYLENIC DERIVATIVES OF ANDROST-4-ENE, THEIR PREPARATION PROCESS, THEIR USE AS A MEDICAMENT AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE59208063D1 (en) Pesticide formulations
FR2449686B1 (en) NOVEL ESTER OF ACID 1- (P-CHLOROBENZOYL) -5-METHOXY-2-METHYLINDOLE-3-ACETIQUE AND ITS PREPARATION, AS WELL AS THE MEDICINAL PRODUCT COMPRISING IT AND ITS PREPARATION
BE878256A (en) NOVEL ACETYLENIC DERIVATIVES OF ANDROST-4-ENE, THEIR PREPARATION PROCESS, THEIR USE AS A MEDICAMENT AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
RU93048335A (en) ORAL DOSAGE FORM, MATERIAL FOR THE SHELL
DE69119884D1 (en) DERIVATIVES OF N-ACYL-N-PHENYLTETRAHYDROPHTHALAMIC ACID, THEIR PRODUCTION AND HERBICIDES THAT CONTAIN THEM AS ACTIVE INGREDIENTS
MC1329A1 (en) ARYLOXY- AND ARYLAMINO-ALKANE-THIOCARBOXAMIDES, THEIR PREPARATION AND THEIR APPLICATION AS ACTIVE INGREDIENTS OF PESTICIDE PRODUCTS
IT7922548A0 (en) DERIVATIVES OF 1,5-DIMETHYLBICYCLO(3.2.1.)-OCTANE, PREPARATION OF THESE COMPOUNDS AND THEIR USE AS COMPOUNDS FOR PERFUMES.
LU81501A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TRIMETHOPRIME, AS WELL AS N-ETHYL-GAMMA-PYRIDONE-3-CARBOXYLIC ACID DERIVATIVES
DE68916443D1 (en) MEDICINES FOR TREATING CRYPTOSPORIDIOSIS.